Review
Individualized therapies in colorectal cancer: KRAS as a marker for response to EGFR-targeted therapy
-
* Corresponding author: David Z Chang David.Chang@USOncology.com
Journal of Hematology & Oncology 2009, 2:18 doi:10.1186/1756-8722-2-18
No comments have yet been made on this article.